头颈癌退伍军人患者颈动脉支架术的单中心长期结局
本研究回顾性分析了1998至2016年间44例有头颈癌治疗史的退伍军人患者,共接受57次颈动脉支架术。平均随访42.9个月,1、5、10年累积生存率分别为91%、67%、48%,原发通畅率分别为95%、86%、86%。结论认为该人群颈动脉支架术的神经系统事件和再干预率低,但生存率差,术前应审慎评估肿瘤预后。
要点
- 头颈癌治疗后颈动脉狭窄患者行CAS的长期神经系统事件和再干预率低。
- 该人群远期生存率差,10年累积生存率仅48%,多数死亡与肿瘤相关。
- 术前应重点评估肿瘤预后,谨慎选择CAS适应证。
核心结论
- 有头颈癌治疗史的退伍军人患者行颈动脉支架术,长期神经系统事件和再干预率低,但生存率差。
- 术前应更审慎评估患者整体预后,尤其是与癌症相关的预后,再决定是否行颈动脉支架术。
研究设计与样本
- 单中心回顾性研究,纳入1998至2016年有头颈癌治疗史并接受颈动脉支架术的退伍军人患者。
- 共44例患者,接受57次颈动脉支架干预,采用Kaplan-Meier分析生存率和原发通畅率。
主要发现
- 平均随访42.9±36.6个月,1、5、10年累积生存率分别为91%、67%、48%。
- 1、5、10年原发通畅率分别为95%、86%、86%,再干预率11%(n=6),辅助原发通畅率100%。
- 30天内无神经系统事件,晚期随访发生3例卒中,无卒中相关死亡。
- 单因素分析显示TNM分期IV期与死亡显著相关(P=0.02),多因素模型对死亡或再干预的预测无统计学意义。
临床怎么用
- 对于有头颈癌治疗史的颈动脉狭窄患者,CAS可作为血运重建选择,但需充分评估肿瘤预后。
- 术前应与肿瘤科协作,对预期生存较短者审慎权衡CAS获益。
局限性
- 单中心回顾性研究,样本量小(44例患者、57次干预)。
- 多因素模型对死亡或再干预的预测无统计学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients meeting criteria for intervention of carotid stenosis with a history of prior cervical radiation or neck dissection are considered "high risk" for carotid endarterectomy. This is a well-established indication for carotid artery stenting (CAS). The long-term outcomes of CAS in this population are less frequently published in the literature but are poor. The purpose of this study was to review long-term results of CAS in veteran patients with a prior history of treatment for head and/or neck cancer. METHODS: This is a retrospective review of a veteran patient population from 1998 to 2016. All patients at our institution with a prior history of treatment for head and/or neck cancer who underwent CAS were included in the analysis. During this time period, 44 patients met inclusion criteria and were treated with 57 carotid stenting interventions. The Kaplan-Meier analysis was used to determine survival and primary patency. The secondary aims were to analyze early outcomes and to identify predictive risk factors for mortality and reintervention. RESULTS: The mean follow-up was 42.9 ± 36.6 months. The cumulative survival at 1, 5, and 10 years was 91%, 67%, and 48%, respectively. The primary patency at 1, 5, and 10 years was 95%, 86%, and 86%, respectively. The reintervention rate was 11% (n = 6) with an assisted primary patency rate of 100%. No neurologic events occurred within 30 days. There were 3 strokes in late follow-up and no stroke-related deaths. Eighteen patients (41%) died during the follow-up period, 15 of whom died during the first 5 years of follow-up. Ten (66%) of those patients died of recurrent or active index cancer. On univariate analysis, tumor, node, metastasis stage IV was significantly associated with death (P = 0.02). Multivariate models were not statistically significant for predicting mortality or reintervention CONCLUSIONS: On the basis of the results in this series, CAS can be performed in these patients with low long-term rates of neurologic events and need for reintervention. However, the survival of patients with head and neck cancer undergoing CAS in this cohort is poor, which is consistent with other published series of patients undergoing CAS for head/neck cancer with at least 5-year follow-up. In this specific patient population, a more critical analysis of the patient's overall prognosis, especially as related to cancer, should be undertaken before offering CAS.
引用
- Jones RW, Conant M, Tanious A, et al. Single Center Outcomes of Carotid Artery Stenting in Veterans with Prior Head and Neck Cancer. Ann Vasc Surg. 2020. PMID: 32795652. doi:10.1016/j.avsg.2020.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。